Management of non-palpable breast lesions with vacuum-assisted large core needle biopsies (Mammotome®) experience with 560 procedures at the Val d'Aurelle Center;Prise en charge des lésions mammaires infra-cliniques par macrobiopsies assistées par le vide (procédure Mammotome®): Expérience du Centre Val d'Aurelle à propos d'une série de 560 procédures

Annales de Pathologie

Volumn 23, Issue 6, 2003, Pages 582-592

  Bibeau, Frédéric ^a   Chateau, Marie Christine ^a   Masson, Bruno ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

Benign breast lesions; Border line breast lesions; Intraductal carcinoma; Microcalcifications; Non palpable breast lesions; Vacuum assisted large needle core biopsy

Indexed keywords

ARTICLE; BENIGN TUMOR; BREAST CARCINOMA; BREAST FIBROSIS; BREAST HYPERPLASIA; BREAST LESION; CANCER INVASION; CLINICAL FEATURE; COLUMNAR EPITHELIUM; DEVICE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; NEEDLE BIOPSY; PATHOLOGIST; PERCUTANEOUS BIOPSY; SCREENING; SURGICAL TECHNIQUE; VACUUM;

BIOPSY, NEEDLE; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE MANAGEMENT; EQUIPMENT DESIGN; FEMALE; FRANCE; HUMANS; HYPERPLASIA; LYMPH NODE EXCISION; METAPLASIA; PALPATION; RETROSPECTIVE STUDIES; VACUUM;

EID: 1842471279     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Darling ML, Smith DN, Lester SC, Kaelin C, Selland D, Denison C et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle biopsy: results of surgical excision. AJR Am J Roentgenol 2000; 175: 1341-6.
2. ANAES. Conduite à tenir diagnostique devant une image mammographique infraclinique anormale. Recommandations pour la Pratique Clinique. Le cancer du sein 1998: 145-79. (http://www.anaes.fr).
3. Bonneau C, Lebas P, Michenet P. Cicatrice et lésions de déplacement. Étude anatomo-pathologique de 31 pièces opératoires après macrobiopsies à l'aiguille de II Gauge pour des foyers de microcalcifications du sein. Ann Pathol 2002; 22: 441-7.
4. MacGrogan G. Des mastopathies à risque aux carcinomes canalaires in situ: lésions élémentaires. Le Sein 2000; 10: 25-35.
5. Anonymous. Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer 1997; 80: 1798-802.
6. Anonyme. Rapport des Pathologistes du Groupe de Travail «Dépistage du Cancer du Sein» de l'Union Européenne. Ann Pathol 1996; 16: 315-33.
7. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001; 25: 229-36.
8. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001; 115: 534-42.
9. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol 2003; 10: 113-24.
10. Frouge C, Guinnebretière JM, Contesso G, Di Paola R, Bénali H, Bléry M. Les microcalcifications associées à une pathologie bénigne. Feuillets Radiol 1994; 34: 380-6.
11. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies. To excise or not to excise? Am J Surg Pathol 2002; 26: 1095-110.
12. Zafrani B, Vincent-Salomon A. Lésions et tumeurs bénignes du sein. Ann Pathol 2000; 20: 570-87.
13. Hoda SA, Rosen PP. Practical considerations in the pathologic diagnosis of needle core biopsies of the breast. Am J Clin Pathol 2002; 118: 101-8.
14. Philipotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000; 216: 831-7.
15. Weaver MG, Abdul-Karim FW, Al-Kaisi N. Mucinous lesions of the breast. A pathological continuum. Pathol Res Pract 1993; 189: 873-6.
16. Otterbach F, Bànkfalvi À, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2000; 37: 232-240.
17. Lacroix-Triki M, Mery E, Voigt JJ, Istier L, Rochaix P. Value of Cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34βE12 antibody. Virchows Arch 2003; 442: 548-54.
18. Zavotsky J, Hansen N, Brennan MB, Turner RR, Giulano AE. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 1999; 85: 2439-43.
19. De Mascarel I, MacGrogan G, Mathoulin-Pélissier S, Soubeyran I, Picot V, Coindre JM. Breast ductal carcinoma in situ with microinvasion. A definition supported by a long-term study of 1248 serially sectionned ductal carcinomas. Cancer 2002; 94: 2134-42.
20. Tavassoli FA, Hoefler H, Rosai J et al. Intraductal proliferative lesions. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumors of the Breast and Female Genitals Organs. Lyon: IARC Press; in press.
21. Sigal-Zafrani B, Vincent-Salomon A, Sastre-Garau X. Risk indicator lesions and carcinoma in situ of the breast. Lobular hyperplasia/neoplasia. Histopathology 2002; 41: 346-63.
22. Renshaw AA, Cartagena N, Derhagopian RP, Goud EW. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002; 117: 797-9.
23. Middleton LP, Shakeitha G, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Modern Pathol 2003; 16: 120-9.
24. Fisher ER, Costantino JP, Fisher B, Palekar AS, Paik SM, Suarez CM et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-years observation concerning lobular carcinoma in situ. Cancer 1996; 78: 1403-16.
25. Shin JS, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Lab Pathol Med 2002; 126: 697-701.
26. Crisi GM, Mandavilli S, Cronin E, Ricci A. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol 2003; 27: 325-33.
27. Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG et al. Combined E-Cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620-7.
28. Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolati G. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 2000; 436: 421-30.
29. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002; 440: 134-8.
30. Liberman L, Sama M, Susnik B, Rosen PP, La Trenta LR, Morris EA et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical findings. Am J Roentgenol 1999; 173: 291-9.
31. Rosai J. Borderline epithelial lesion of the breast. Am J Surg Pathol 1991; 15: 209-21.
32. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R et al. Interobserver reproductibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992; 16: 1133-43.
33. Sneige N, Lim S C, Whitman GJ, Krishnamurthy S, Sahin AA, Smith TL et al. Atypical ductal hyperplasia diagnosis by directionnal vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 2003; 119: 248-53.
34. Ely KA, Carter BA Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 2001; 25: 1017-21.
35. Trojani M. Atlas en couleurs d'histopathologie mammaire. Paris: Maloine, 1988.
36. Rosen PP. Columnar cell hyperplasia is associated with lobular in situ carcinoma and tubular carcinoma. Am J Surg Pathol 1999; 23: 1561.
37. Goldstein NS, O'Malley BA. Cancerisation of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma. Am J Clin Pathol 1997; 107: 561-6.
38. Oyama T, Maluf H, Koemer F. Atypical cystic lobules: an early stage in the formation of low-grade ductal carcinoma in situ. Virchows Arch 1999; 435: 413-21.
39. Fraser JL, Raza S, Chomy K Connolly JL, Schnitt SJ. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 1998; 22: 1521-7.
40. Molimard J. Des mastopathies à risque aux carcinomes canalaires in situ. Reproductibilité de l'identification et de la classification des lésions. Que faut-il mettre dans le compte-rendu? Standards et recommandations. Le sein 2000; 10: 36-43.
41. Anonymous. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. NHS Cancer screening programmes 2001; 50.
42. Hoda SA, Harigopal M. Expert opinion. Reporting needle core biopsies of breast in situ carcinomas. Histopathology 2003; 43: 84-90.
43. Sigal-Zafrani B, Vincent-Salomon A, Meunier M, El Khoury C, Thibault F, Sastre-Garau X. Place du pathologiste dans les nouvelles stratégies thérapeutiques. L'expérience de la pathologie mammaire. Analyse des micro/macrobiopsies de lésions mammaires infra-cliniques. Est-elle représentative des lésions? Comment formuler les comptes-rendus? Ann Pathol 2002; 22: S48-9.